Associate Medical Director, Global Apheresis
Specialist in Therapeutic Plasma Exchange & Full-Spectrum Apheresis – Advancing precision care for longevity, Alzheimer's, inflammation, and autoimmune disorders.
Therapeutic Plasma Exchange (TPE/PLEX) is a groundbreaking procedure that removes old plasma and replaces it with a 5% albumin solution, a powerful antioxidant and anti-inflammatory compound.
This process clears harmful age-related compounds, resets body systems, reduces inflammation, and activates stem cells to boost health and combat disease. PLEX represents a paradigm shift in how we approach health and longevity.
Your plasma accumulates harmful compounds over time: inflammatory cytokines, oxidized proteins, and senescent factors that accelerate aging. PLEX removes these substances while introducing powerful therapeutic properties through albumin replacement.
See The Process →At Global Apheresis, therapeutic plasma exchange (PLEX/TPE) is our cornerstone procedure for longevity, Alzheimer's, and inflammation. We also offer comprehensive apheresis services:
Complete plasma removal and replacement with 5% albumin solution to clear inflammatory cytokines, oxidized proteins, and senescent factors that accelerate aging and disease.
Flagship ServiceTargeted removal of excess lipids for refractory hypercholesterolemia and cardiovascular risk reduction.
Specialized white blood cell and stem cell collection services. Working with leading biotechnology companies to advance emerging stem cell protocols for longevity and regenerative medicine.
Removes inflammatory molecules, oxidized proteins, and senescent factors that accumulate with age, restoring youthful cellular function and vitality.
Restores optimal signaling between organs and tissues, resetting metabolic, immune, and regenerative systems to more youthful states of operation.
The 5% albumin solution provides powerful antioxidant and anti-inflammatory effects, combating chronic inflammation, a root cause of aging and disease.
Fresh plasma creates an environment that awakens dormant stem cells, enhancing your body's natural regenerative capacity and repair mechanisms.
Patients report increased energy, improved cognitive function, enhanced physical performance, and an overall sense of renewed vitality.
By addressing underlying inflammatory and degenerative processes, PLEX helps prevent and manage chronic diseases while promoting longevity.
A safe, sophisticated procedure performed by trained medical professionals in a comfortable clinical setting.
IV access is obtained in each arm, similar to a routine blood draw. This provides the access point for the exchange process.
Your blood flows through an advanced apheresis machine that gently separates plasma from blood cells using centrifugal technology.
Old plasma containing inflammatory compounds is removed. Fresh 5% albumin solution is introduced as a powerful antioxidant replacement.
Your blood cells, now suspended in rejuvenating albumin solution, are returned to your body, beginning cellular renewal.
Board-Certified Clinical Pathologist & Apheresis Specialist
Dr. Green's path to medicine was unconventional. After serving in the Active Duty Air Force as a squadron physical training leader and working as a personal trainer, he realized he wanted to address health holistically. This led him to medical school and ultimately to specializing in clinical pathology and therapeutic plasma exchange.
His fascination with PLEX began during medical school when he discovered its profound applications for longevity and Alzheimer's disease treatment. He completed his residency at UT Southwestern under Dr. Ravi Sarode, one of the world's foremost experts in apheresis and transfusion medicine, and established a professional relationship with pioneer Dr. Dobri Kiprov.
With over 500 TPE procedures focused on biological age reversal and prevention of age-related diseases, Dr. Green now serves as Associate Medical Director at Global Apheresis, where he leads clinical operations and research initiatives. He also serves as medical director for Global Apheresis affiliate partnerships, expanding access to evidence-based therapeutic apheresis nationwide through clinical training, protocol development, and quality oversight.
View Full Journey →Discovered revolutionary aging research using Therapeutic Plasma Exchange for longevity and Alzheimer's Disease through independent study at The Medical University of South Carolina.
Entered clinical pathology residency, gaining expertise in apheresis technologies under field leaders including Dr. Ravi Sarode. Supervised and performed hundreds of apheresis procedures.
Joined a bone marrow transplant group, collecting stem cells via apheresis for the treatment of blood cancers, including acute leukemias and multiple myeloma.
Launched and scaled the flagship longevity clinic in Dallas, TX, from 0 to 50 therapeutic plasma exchange procedures per month.
Leading comprehensive apheresis programs at Global Apheresis utilizing therapeutic plasma exchange, cellular collection technologies, and emerging lipid apheresis. Partnering with biotechnology companies to develop novel stem cell protocols for longevity, health optimization, and preventative medicine. Additionally serving as medical director for Global Apheresis affiliate clinic partnerships, providing clinical training, protocol development, and quality oversight to expand access to therapeutic apheresis nationwide.
Blood Vessels, Thrombosis & Hemostasis
Demonstrates a personalized approach to caplacizumab dosing guided by ADAMTS13 activity monitoring, optimizing treatment outcomes in iTTP.
View PaperAmerican Society for Apheresis Annual Conference, Las Vegas
Retrospective analysis evaluating the safety and efficacy of maintaining heparin infusions during TPE procedures, informing best practices for anticoagulation management.
Update in Pathophysiology, Department of Pathology, UT Southwestern
Comprehensive invited lecture covering the mechanistic basis of TPE and its expanding therapeutic applications across longevity and disease management.
Transfusion and Apheresis Science
Reports a novel case highlighting the intersection of hyperhemolysis syndrome in sickle cell disease complicated by concurrent SARS-CoV-2 infection.
View PaperAmerican Society for Apheresis Annual Meeting, Minneapolis, MN
Poster presentation examining therapeutic plasma exchange outcomes in systemic sclerosis patients.
Annals of Hematology
First reported use of lenalidomide for refractory acquired von Willebrand disease in the setting of monoclonal gammopathy, demonstrating a novel therapeutic approach.
View PaperAssociation for the Advancement of Blood & Biotherapies Annual Meeting, Orlando, FL
Analysis of red blood cell inventory impacts when implementing extended antigen matching protocols for chronic transfusion patients.
Computers in Biology and Medicine
Computational analysis identifying potential antiviral compounds targeting SARS-CoV-2 structural and non-structural proteins using pharmacoinformatics approaches.
View PaperJournal of Clinical Microbiology
Clinical evaluation of quantitative antibody assays for SARS-CoV-2 among infected, recovered, and vaccinated populations.
View PaperJournal of Clinical Apheresis
Case report demonstrating successful use of therapeutic plasma exchange for managing hyperviscosity syndrome in juvenile rheumatoid arthritis.
View Paper
How I joined the pioneering team advancing therapeutic apheresis for longevity and health optimization.
Read More →
Therapeutic plasma exchange produces measurable changes in biological age clocks, inflammatory proteins, and environmental toxins.
Read on DrPlexMD.com
The game-changing finding: 30% of AMBAR patients were amyloid-negative yet benefited equally from plasma exchange treatment.
Read on DrPlexMD.comBook a discovery call to discuss how Therapeutic Plasma Exchange can help you achieve your health and longevity goals. Virtual and in-person options available.
